Drug abuse researchers gathered at a symposium in Sikkim, one of India’s smallest states, to tackle some of the region’s biggest health problems. Linda Cottler, Ph.D., M.P.H., a NIDA grantee, offered her expertise at the symposium in Gangtok, the capital of Sikkim, to help begin to shed light on the magnitude of substance abuse in the state.
NIDA International Forum Focuses on Commonalities Among the Diseases of Addiction
Drugs. Sex. Gambling. Obesity.
Plenary session speakers at the 14th NIDA International Forum documented the commonalities among these "Disorders of Desire," citing clear overlaps in implicated brain regions and similar patterns of compulsive self-administration, tolerance, craving, comorbidity, disruption of inhibitory control, and impaired decision-making.
In a keynote address at the Partnering for Global Health Forum this past June, National Institutes of Health (NIH) Director Francis S. Collins, M.D., Ph.D., emphasized the importance of collaborative global health research to NIH and the United States.
Answering the question of why NIH should support global research, Dr. Collins noted, “What we learn in carrying out research in global health benefits our own citizens as well.” Quoting Julio Frenk, M.D., Ph.D., Dean, Harvard School of Public Health, Dr. Collins emphasized “Global is not the opposite of domestic.”
More than 260 participants from 61 countries attended the 17th Annual NIDA International Forum, which was held June 8–11, 2012, in Palm Springs, California. The meeting focused on the growing public health problem of new and emerging psychoactive substances, which are mostly unregulated compounds that are specifically designed to circumvent drug laws and mimic the effects of illicit drugs by slightly altering the chemical structure of a known drug. A joint College on Problems of Drug Dependence (CPDD)/NIDA International Forum poster session featured presentations by 160 U.S.
Drug abuse researchers from Brazil, Mexico, and Taiwan presented their research and sought feedback on upcoming clinical trials during the International Collaboration Workshop held at the recent NIDA Clinical Trials Network (CTN) Steering Committee Meeting.
The meeting is a featured breakout session of the 3-day NIDA CTN Steering Committee Meeting. International presenters included Ronaldo Laranjeira, M.D., Federal University of Sao Paulo; Ming-Chyi Huang, M.D., Ph.D., Taipei City Psychiatric Center; and Chun-Hsin Chen, M.D., M.S., Taipei Medical University–Wang Fang Hospital.
Building on the 2011 binational agreement between NIDA and the Italian Department for Anti-Drug Policies (DAP), Italy has translated the NIDA website, Easy-to-Read Drug Facts, into Italian. The easy-to-read website features pictures and videos to help readers understand the text about drug abuse, addiction, and treatment. The pages are easy to print out to share with people who do not have computers.
Abstracts will soon be accepted for the 5th Annual NIDA International Poster Session at the Society for Prevention Research (SPR) 20th Annual Meeting in Washington, DC, May 29–June 1, 2012.
NIDA’s International Program and Division of Epidemiology, Services and Prevention Research will host the poster session to highlight international drug abuse-related prevention research, including HIV/AIDS prevention research in drug-using populations. Abstract submissions will undergo the same peer review process as other poster submissions for SPR.
Register On Site! Health Disparities, Women, and Substance Abuse: Global Issues
Friday, June 14, 11 a.m. to 6 p.m. Hilton Bayfront Hotel, San Diego, California
Registration: $75 ($35 for participants from developing countries)